|
1
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality
Worldwide: IARC CancerBase No. 11. International Agency for
Research on Cancer; Lyon: 2013, http://globocan.iarc.fr.
Accessed Dec 01, 2014
|
|
2
|
Boland CR, Shin SK and Goel A: Promoter
methylation in the genesis of gastrointestinal cancer. Yonsei Med
J. 50:309–321. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Spengler D, Villalba M, Hoffmann A,
Pantaloni C, Houssami S, Bockaert J and Journot L: Regulation of
apoptosis and cell cycle arrest by Zac1, a novel zinc finger
protein expressed in the pituitary gland and the brain. EMBO J.
16:2814–2825. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abdollahi A: LOT1 (ZAC1/PLAGL1) and its
family members: Mechanisms and functions. J Cell Physiol.
210:16–25. 2007. View Article : Google Scholar
|
|
5
|
Abdollahi A, Pisarcik D, Roberts D,
Weinstein J, Cairns P and Hamilton TC: LOT1 (PLAGL1/ZAC1), the
candidate tumor suppressor gene at chromosome 6q24-25, is
epigenetically regulated in cancer. J Biol Chem. 278:6041–6049.
2003. View Article : Google Scholar
|
|
6
|
Basyuk E, Coulon V, Le Digarcher A,
Coisy-Quivy M, Moles JP, Gandarillas A and Journot L: The candidate
tumor suppressor gene ZAC is involved in keratinocyte
differentiation and its expression is lost in basal cell
carcinomas. Mol Cancer Res. 3:483–492. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bilanges B, Varrault A, Basyuk E,
Rodriguez C, Mazumdar A, Pantaloni C, Bockaert J, Theillet C,
Spengler D and Journot L: Loss of expression of the candidate tumor
suppressor gene ZAC in breast cancer cell lines and primary tumors.
Oncogene. 18:3979–3988. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cvetkovic D, Pisarcik D, Lee C, Hamilton
TC and Abdollahi A: Altered expression and loss of heterozygosity
of the LOT1 gene in ovarian cancer. Gynecol Oncol. 95:449–455.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abdollahi A, Roberts D, Godwin AK, Schultz
DC, Sonoda G, Testa JR and Hamilton TC: Identification of a
zinc-finger gene at 6q25: A chromosomal region implicated in
development of many solid tumors. Oncogene. 14:1973–1979. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jacobs DI, Mao Y, Fu A, Kelly WK and Zhu
Y: Dysregulated methylation at imprinted genes in prostate tumor
tissue detected by methylation microarray. BMC Urol. 13:372013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pagotto U, Arzberger T, Theodoropoulou M,
Grübler Y, Pantaloni C, Saeger W, Losa M, Journot L, Stalla GK and
Spengler D: The expression of the antiproliferative gene ZAC is
lost or highly reduced in non-functioning pituitary adenomas.
Cancer Res. 60:6794–6799. 2000.
|
|
12
|
Koy S, Hauses M, Appelt H, Friedrich K,
Schackert HK and Eckelt U: Loss of expression of ZAC/LOT1 in
squamous cell carcinomas of head and neck. Head Neck. 26:338–344.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dai YC, Zhu XS, Nan QZ, Chen ZX, Xie JP,
Fu YK, Lin YY, Lian QN, Sang QF and Zhan XJ: Identification of
differential gene expressions in colorectal cancer and polyp by
cDNA microarray. World J Gastroenterol. 18:570–575. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Flatmark K, Maelandsmo GM, Martinsen M,
Rasmussen H and Fodstad Ø: Twelve colorectal cancer cell lines
exhibit highly variable growth and metastatic capacities in an
orthotopic model in nude mice. Eur J Cancer. 40:1593–1598. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fujii H, Zhou W and Gabrielson E:
Detection of frequent allelic loss of 6q23-q25.2 in microdissected
human breast cancer tissues. Genes Chromosomes Cancer. 16:35–39.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bilanges B, Varrault A, Mazumdar A,
Pantaloni C, Hoffmann A, Bockaert J, Spengler D and Journot L:
Alternative splicing of the imprinted candidate tumor suppressor
gene ZAC regulates its antiproliferative and DNA binding
activities. Oncogene. 20:1246–1253. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Varrault A, Ciani E, Apiou F, Bilanges B,
Hoffmann A, Pantaloni C, Bockaert J, Spengler D and Journot L: hZAC
encodes a zinc finger protein with antiproliferative properties and
maps to a chromosomal region frequently lost in cancer. Proc Natl
Acad Sci USA. 95:8835–8840. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Enlund F, Persson F and Stenman G:
Molecular analyses of the candidate tumor suppressor gene, PLAGL1,
in benign and malignant salivary gland tumors. Eur J Oral Sci.
112:545–547. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jarmalaite S, Laurinaviciene A,
Tverkuviene J, Kalinauskaite N, Petroska D, Böhling T and
Husgafvel-Pursiainen K: Tumor suppressor gene ZAC/PLAGL1: Altered
expression and loss of the nonimprinted allele in
pheochromocytomas. Cancer Genet. 204:398–404. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abdollahi A, Bao R and Hamilton TC: LOT1
is a growth suppressor gene down-regulated by the epidermal growth
factor receptor ligands and encodes a nuclear zinc-finger protein.
Oncogene. 18:6477–6487. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schlessinger J: Cell signaling by receptor
tyrosine kinases. Cell. 103:211–225. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yarden Y: The EGFR family and its ligands
in human cancer. signalling mechanisms and therapeutic
opportunities. Eur J Cancer. 37(Suppl 4): S3–S8. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Spano JP, Lagorce C, Atlan D, Milano G,
Domont J, Benamouzig R, Attar A, Benichou J, Martin A, Morere JF,
et al: Impact of EGFR expression on colorectal cancer patient
prognosis and survival. Ann Oncol. 16:102–108. 2005. View Article : Google Scholar
|
|
27
|
Cheirsilpa A, Ruangvejvorachai P, Karalak
A, Sangprakarn S, Pummai S and Sangrajrang S: Determination of
epidermal growth factor receptor (EGFR) in patients with colorectal
cancer (Institutional series). Cancer Ther. 5:137–142. 2007.
|
|
28
|
Huang SM and Stallcup MR: Mouse Zac1, a
transcriptional coactivator and repressor for nuclear receptors.
Mol Cell Biol. 20:1855–1867. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Theocharis S, Kouraklis G, Margeli A,
Agapitos E, Ninos S, Karatzas G and Koutselinis A: Glucocorticoid
receptor (GR) immunohistochemical expression is correlated with
cell cycle-related molecules in human colon cancer. Dig Dis Sci.
48:1745–1750. 2003. View Article : Google Scholar : PubMed/NCBI
|
